Yes that is important too, thus my comments around an assessment of the commercial opportunity being work still to come. However biotech companies in phase 2 are essentially options and it is instructive to see how the market is valuing comparable options. If you knew nothing else this would still be helpful information.
Yes that is important too, thus my comments around an assessment...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
